Follow
Jordan Rossen
Jordan Rossen
Department of Epidemiology, Harvard T.H. Chan School of Public Health
Verified email at g.harvard.edu
Title
Cited by
Cited by
Year
Copper induces cell death by targeting lipoylated TCA cycle proteins
P Tsvetkov, S Coy, B Petrova, M Dreishpoon, A Verma, M Abdusamad, ...
Science 375 (6586), 1254-1261, 2022
18392022
Discovering the anticancer potential of non-oncology drugs by systematic viability profiling
SM Corsello, RT Nagari, RD Spangler, J Rossen, M Kocak, JG Bryan, ...
Nature cancer 1 (2), 235-248, 2020
5062020
Mitochondrial metabolism promotes adaptation to proteotoxic stress
P Tsvetkov, A Detappe, K Cai, HR Keys, Z Brune, W Ying, P Thiru, ...
Nature chemical biology 15 (7), 681-689, 2019
3242019
Extracting biological insights from the project achilles genome-scale CRISPR screens in cancer cell lines
JM Dempster, J Rossen, M Kazachkova, J Pan, G Kugener, DE Root, ...
BioRxiv, 720243, 2019
2912019
Non-oncology drugs are a source of previously unappreciated anti-cancer activity
SM Corsello, RT Nagari, RD Spangler, J Rossen, M Kocak, JG Bryan, ...
BioRxiv, 730119, 2019
352019
Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling. Nat Cancer. 2020; 1: 235–48
SM Corsello, RT Nagari, RD Spangler, J Rossen, M Kocak, JG Bryan
62022
Adenosine receptor antagonists exhibit potent and selective off-target killing of FOXA1-high cancers
SM Corsello, RD Spangler, R Humeidi, CN Harrington, RT Nagari, ...
Cancer Research 80 (16_Supplement), 3400-3400, 2020
12020
Abstract B121: An oncogene-linked prodrug strategy in lung cancer
A Boudreau, J Roth, J Rong, N Olsson, C Mader, J Byran, J Rossen, ...
Molecular Cancer Therapeutics 18 (12_Supplement), B121-B121, 2019
2019
Massively parallel multiplexed methods to screen hundreds of barcoded cancer cell line models with small molecules or genetic perturbations using next-generation sequencing
S Bender, C Zhu, L Wang, M Rothberg, J Dempster, B Paolella, M Kocak, ...
Cancer Research 79 (13_Supplement), 2690-2690, 2019
2019
Novel cell line barcoding method reveals tepoxalin as a selective drug against MDR1-high tumor cells
SM Corsello, RD Spangler, RT Nagari, M Kocak, J Rossen, P O'Hearn, ...
Cancer Research 79 (13_Supplement), 2948-2948, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–10